Vanadate activated Akt and promoted S phase entry

Molecular and Cellular Biochemistry

Volumn 255, Issue 1-2, 2004, Pages 227-237

  Zhang, Zhuo ^a,b   Gao, Ning ^b   He, Hengjun ^b   Huang, Chuanshu ^c   Luo, Jia ^b   Shi, Xianglin ^a,b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Cell cycle regulation; E2F1; PI3k; pRb; Vanadate

Indexed keywords

CYCLIN A; CYCLIN E; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; RETINOBLASTOMA PROTEIN; SERINE; THREONINE; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; VANADIC ACID;

ANIMAL CELL; CELL COUNT; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; CELL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; DOWNSTREAM PROCESSING; GENETIC TRANSFECTION; LUNG CANCER; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE; CYCLIN E; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RETINOBLASTOMA PROTEIN; S PHASE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VANADATES;

ANIMALIA;

EID: 0742324105     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000007278.27936.8b     Document Type: Review

References (46)

1. Kops GJ, Medema RH, Glassford J, Essers MA, Dijkers PF, Coffer PJ, Lam EW, Burgering BM: Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol 22: 2025-2036, 2002
2. Coffer PJ, Jin J, Woodgett JR: Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335: 1-13, 1998
3. Bellacosa A, Franke TF, Gonzalez-Portal ME, Datta K, Taguchi T, Gardner J, Cheng JQ, Testa JR, Tsichlis PN: Structure, expression and chromosomal mapping of c-akt: Relationship to v-akt and its implications. Oncogene 8: 745-754, 1993
4. Blume-Jensen P, Hunter T: Oncogenic kinase signalling. Nature 411: 355-365, 2001
5. Brennan P, Babbage JW, Burgering BM, Groner B, Reif K, Cantrell DA: Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7: 679-689, 1997
6. Dyson N: The regulation of E2F by pRB-family proteins. Genes Dev 12: 2245-2262, 1998
7. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995
8. Weintraub SJ, Prater CA, Dean DC: Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358: 259-261, 1992
9. Bosco G, Du W, Orr-Weaver TL: DNA replication control through interaction of E2F-RB and the origin recognition complex. Nat Cell Biol, 3: 289-295, 2001
10. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996
11. Hori CaO T: Vanadate enhances the stimulatory action of insurin on DNA synthesis in cultured mouse mammary glands. Biochim Biophys Acta 610: 235-240, 1987
12. Nechay BR, Nanninga LB, Nechay PS: Vanadyl (IV) and vanadate (V) binding to selected endogenous phosphate, carboxyl, and amino ligands; calculations of cellular vanadium species distribution. Arch Biochem Biophys 251: 128-138, 1986
13. Sabbioni E, Pozzi G, Pintar A, Casella L, Garattini S: Cellular retention, cytotoxicity and morphological transformation by vanadium(IV) and vanadium(V) in BALB/3T3 cell lines. Carcinogenesis 12: 47-52, 1991
14. Carpenter G: Vanadate, epidermal growth factor and the stimulation of DNA synthesis. Biochem Biophys Res Commun 102: 1115-1121, 1981
15. Hickey RJ, Schoff EP, Clelland RC: Relationship between air pollution and certain chronic disease death rates. Multivariate statistical studies. Arch Environ Health 15: 728-738, 1967
16. Leonard A, Gerber GB: Mutagenicity, carcinogenicity and teratogenicity of vanadium compounds. Mutat Res 317: 81-88, 1994
17. Stock P: On the relations between atmospheric pollution in urban and rural location and mortality from cancer, bronchitis, pneumonia, with particular reference to 3,4-benzopyrene, beryllium, molybdenum, vanadium and arsenic. Br J Cancer 14: 397-418, 1965
18. Zhong BZ, Gu ZW, Wallace WE, Whong WZ, Ong T: Genotoxicity of vanadium pentoxide in Chinese hamster V79 cells. Mutat Res 321: 35-42, 1994
19. Zhang, Z, Huang C, Li J, Leonard SS, Lanciotti R, Butterworth L, Shi X: Vanadate-induced cell growth regulation and the role of reactive oxygen species. Arch Biochem Biophys 392: 311-320, 2001
20. Zhang Z, Huang C, Li J, Shi X: Vanadate-induced cell growth arrest is p53-dependent through activation of p21 in C141 cells. J Inorg Biochem 89: 142-148, 2002
21. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279, 1991
22. Sgonic Raw G: Methods for the detection of apoptosis. Int Arch Allergy Immunol 105: 327-332, 1994
23. Stern A, Yin X, Tsang SS, Davison A, Moon J: Vanadium as a modulator of cellular regulatory cascades and oncogene expression. Biochem Cell Biol 71: 103-112, 1993
24. Cruz TF, Morgan A, Min W: In vitro and in vivo antineoplastic effects of orthovanadate. Mol Cell Biochem 153: 161-166, 1995
25. Shackelford RE, Kaufmann WK, Paules RS: (1999) Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ Health Perspect 107 (suppl 1): 5-24.
26. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM: Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257: 1689-1694, 1992
27. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, Roberts JM: Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66: 1217-1228, 1991
28. Chan TO, Rittenhouse SE, Tsichlis PN: AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 68: 965-1014, 1999
29. Sable CL, Filippa N, Hemmings B, Van Obberghen E: cAMP stimulates protein kinase B in a Wortmannin-insensitive manner. FEBS Lett 409: 253-257, 1997
30. Konishi H, Matsuzaki H, Tanaka M, Takemura Y, Kuroda S, Ono Y, Kikkawa U: Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27. FEBS Lett 410: 493-498, 1997
31. Konishi H, Matsuzaki H, Tanaka M, Ono Y, Tokunaga C, Kuroda S, Kikkawa U: Activation of RAC-protein kinase by heat shock and hyperosmolarity stress through a pathway independent of phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 93: 7639-7643, 1996
32. 2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem J 336: 241-246, 1998
33. Huang C, Li J, Ding M, Leonard SS, Wang L, Castranova V, Vallyathan V, Shi X: UV Induces phosphorylation of protein kinase B (Akt) at Ser-473 and Thr-308 in mouse epidermal Cl 41 cells through hydrogen peroxide. J Biol Chem 276: 40234-40240, 2001
34. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN: The protein kinase encoded by the Akt protooncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736, 1995
35. Franke TF, Kaplan DR, Cantley LC, Toker A: Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275: 665-668, 1997
36. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S: Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: Critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 276: 27462-27469, 2001
37. Andjelkovic M, Alessi DR, Meier R, Fernandez A, Lamb NJ, Frech M, Cron P, Cohen P, Lucocq JM, Hemmings BA: Role of translocation in the activation and function of protein kinase B. J Biol Chem 272: 31515-31524, 1997
38. Toker A, Newton AC: Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J Biol Chem 275: 8271-8274, 2000
39. Scheid MP, Woodgett JR: PKB/AKT: Functional insights from genetic models. Nat Rev Mol Cell Biol 2: 760-768, 2001
40. Sherr CJ, Roberts JM: CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999
41. Trimarchi JM, Lees JA: Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3: 11-20, 2002
42. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ: Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548, 1996
43. Meng RD, Phillips P, El-Deiry WS: p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Int J Oncol 14: 5-14, 1999
44. Lin WC, Lin FT, Nevins JR: Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 15: 1833-1844, 2001
45. Gille H, Downward J: Multiple ras effector pathways contribute to G(1) cell cycle progression. J Biol Chem 274: 22033-22040, 1999
46. Berkovich E, Ginsberg D: Ras induces elevation of E2F-1 mRNA levels. J Biol Chem 276: 42851-42856, 2001